Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Combination of imaging exams improves Alzheimer’s diagnosis

Dementia TodayPublished December 11, 20124 min read

Key points

  • A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer’s disease, according to a new study published online in the journal Radiology.
  • According to the World Health Organization, more than 35 million people worldwide are living with Alzheimer’s disease, which is incurable, and the prevalence is expected to double by 2030.
  • The Duke study looked at 97 patients with MCI from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a national multicenter biomarker study in which patients are followed serially to track disease progression.
  • The researchers also analyzed the individual contributions of the various exams.

A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer’s disease, according to a new study published online in the journal Radiology.

“Because new treatments are likely to be most effective at the earliest stages of Alzheimer’s disease, there is great urgency to develop sensitive markers that facilitate detection and monitoring of early brain changes in individuals at risk,” said Jeffrey R. Petrella, M.D., associate professor of radiology, division of neuroradiology, and director of the Alzheimer’s Disease Research Lab at Duke University Medical Center (DUMC) in Durham, N.C. “Our study looks at whether more sophisticated diagnostic tests such as magnetic resonance imaging (MRI), positron emission tomography (PET) and spinal fluid protein analysis might provide additional prognostic information, compared to more readily available cognitive and blood testing.”

According to the World Health Organization, more than 35 million people worldwide are living with Alzheimer’s disease, which is incurable, and the prevalence is expected to double by 2030.

“Although there is no cure for Alzheimer’s disease, there are four symptomatic treatments that might provide some benefits,” said coauthor P. Murali Doraiswamy, M.D., professor of psychiatry at DUMC. “So developing the right combination of diagnostic tests is critical to make sure we enable an accurate and early diagnosis in patients, so they can evaluate their care options.”

The Duke study looked at 97 patients with MCI from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a national multicenter biomarker study in which patients are followed serially to track disease progression. The researchers analyzed baseline MRI and FDG-PET results, as well as cerebrospinal fluid proteins and compared these to cognitive outcomes at two to three years.

The findings showed that combining MRI, FDG-PET and cerebrospinal fluid data with routine clinical tests significantly increased the accuracy of predicting conversion to Alzheimer’s disease over clinical testing alone. In addition, the combined testing reduced false classifications. The misclassification rate decreased from 41.3 percent to 28.4 percent.

The researchers also analyzed the individual contributions of the various exams.

“In an ideal world, you’d obtain all information available—regardless of cost or number of tests—for the best prediction of cognitive decline,” Dr. Petrella said. “However, there’s a trade-off between adding testing—some of which may add little new information—with the inconvenience, cost and risk to the patient.”

Among the exams, FDG-PET contributed more information to routine tests than did cerebrospinal fluid or MRI.

“Though all the tests added some unique information,” Dr. Petrella said, “FDG-PET appeared to strike the best balance, adding the most prognostic information for patients with mild cognitive impairment.”

The researchers caution that additional long-term studies are needed to further validate the data.

ADNI was launched in 2003 and is a national, multi-site study of elderly patients with and without Alzheimer’s disease and MCI. ADNI is the result of efforts of many co-investigators from academic institutions and private corporations. Patients were recruited from over 50 sites across the U.S. and Canada.

###

“Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers.” Collaborating with Dr. Petrella were Jennifer L Shaffer, M.D., Forrest C Sheldon, B.S., Kingshuk Roy Choudhury, Ph.D., Vince D Calhoun, Ph.D., R. Edward Coleman, M.D., and P. Murali Doraiswamy, M.D., for the Alzheimer’s Disease Neuroimaging Initiative.

Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc.

RSNA is an association of more than 50,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill.

###

Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Filed underDementia News

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.